[Retracted] Effects of Ulinastatin on Myocardial Ischemia-Reperfusion Injury, Cardiac Function, and Serum TNF-α and IL-10 Levels in Patients Undergoing Cardiac Valve Replacement under Cardiopulmonary Bypass

Table 1

Clinical baseline data ( (%)).

	Obs group	Con group	/
Age			0.695	0.489
Gender			0.369	0.543
Male	31 (59.62)	34 (65.38)
Female	21 (40.38)	18 (34.62)
Type of disease			0.378	0.828
Congenital heart valve disease	17 (32.69)	20 (38.46)
Degenerative disease	13 (25.00)	12 (23.08)
Rheumatic valvular disease	22 (42.31)	20 (38.46)
Type of surgery			0.175	0.676
Tricuspid valve replacement	18 (34.62)	16 (30.77)
Mitral valve replacement	34 (65.38)	36 (69.23)
Valve type			0.633	0.426
Mechanical valve	42 (80.77)	45 (86.54)
Biological valve	10 (19.23)	7 (13.46)
Family history of illness			0.377	0.539
Have	7 (13.46)	5 (9.62)
None	45 (86.54)	47 (90.38)
Smoking			0.650	0.420
Yes	22 (42.31)	18 (34.62)
No	30 (57.69)	34 (65.38)
Drinking			0.046	0.830
Yes	16 (30.77)	15 (28.85)
No	36 (69.23)	37 (71.15)
Living environment			0.633	0.426
City	42 (80.77)	45 (86.54)
Countryside	10 (19.23)	7 (13.46)